Browsing the "Neurosciences" Category

St. Luke’s Neurology Associates Expands to Meet Growing Demand

October 2nd, 2015

St. Luke’s Neurology Associates has been actively recruiting new physicians to meet an ever-growing market demand. The practice has increased opportunities both regionally and by service. St. Luke’s is pleased to announce the following appointments: General Neurologists Mahesh Chhabria, MD Raj Katara, MD James Kerrigan, MD Heeral J. Mehta, MD Epileptologist Scott Kohler, MD Neurohospitalist

St. Luke’s Performs First Live Feed Surgery with Medtronic, 
World’s Largest Medical Device Company

August 7th, 2015

St. Luke’s University Health Network’s functional neurosurgeon Steven Falowski, MD, has partnered with Medtronic medical device company to promote faster and better product development within the field of neuromodulation for patients with pain and disability related to nerve disorders. Many of the patients’ pain and disability is a result of brain tumors, Parkinson’s disease and head

Epilepsy Monitoring Unit (EMU)

February 23rd, 2015

The inpatient Epilepsy Monitoring Unit (EMU) at St. Luke’s University Hospital-Bethlehem features both EEG (electroencephalography) equipment to monitor brain activity and video cameras to record body movements during a seizure.

Fellowship-trained Physicians Join St. Luke’s Center for Neuroscience

December 3rd, 2014

St. Luke’s Neurology Associates are pleased to welcome five new physicians to its team of experts. Sameer Ali, MD, has joined St. Luke’s as a neurohospitaliSt. Dr. Ali attended medical school at Wright State School of Medicine in Dayton, Ohio and completed his neurology residency at SUNY Upstate Medical Center in Syracuse, New York and advanced fellowship training in

Dr. Falowski is Appointed Expert to the Neuromodulation Appropriateness Consensus Committee (NACC)

December 3rd, 2014

In August, the International Neuromodulation Society (INS) announced it would soon publish the first peer-reviewed comprehensive expert guidance on the appropriate use of neurostimulation for pain. The INS Board of Directors recognized the need to better define the appropriate use of these advanced tools, and appointed experts to the Neuromodulation Appropriateness Consensus Committee (NACC) to